AstraZeneca KK:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AstraZeneca KK - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10939
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AstraZeneca KK (AstraZeneca) a subsidiary of AstraZeneca Plc is a drug company that provides prescription medicines. The company offers products such as akoreto, arimidex, iressa, inderal, casodex, crestor, and other tablets. It offers products for oncology, cardiovascular and metabolic diseases, respiratory and autoimmune diseases. AstraZeneca also offers treatment of EGFR T790M mutation positive for non-small cell lung cancer. The company has presence in Sapporo, Tokyo, Saitama, Osaka, Hiroshima and Fukuoka. It operates through its factory and distribution center located in Maibara and Ibaraki. AstraZeneca is headquartered in Osaka, Japan.

AstraZeneca KK – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AstraZeneca KK, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AstraZeneca KK, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 10
AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 11
AstraZeneca Enters Into Agreement With Bristol-Myers To Commercialize Dapagliflozin In Japan 12
Acquisition 13
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 13
AstraZeneca KK – Key Competitors 15
AstraZeneca KK – Key Employees 16
AstraZeneca KK – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
AstraZeneca KK, Pharmaceuticals & Healthcare, Key Facts 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AstraZeneca KK, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AstraZeneca KK, Deals By Therapy Area, 2012 to YTD 2018 8
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 10
AstraZeneca Enters Into Co-Promotion Agreement With Ono Pharma For Dapagliflozin 11
AstraZeneca Enters Into Agreement With Bristol-Myers To Commercialize Dapagliflozin In Japan 12
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 13
AstraZeneca KK, Key Competitors 15
AstraZeneca KK, Key Employees 16
AstraZeneca KK, Other Locations 17

List of Figures
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AstraZeneca KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[AstraZeneca KK:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Churchill Downs Incorporated:企業の戦略・SWOT・財務情報
    Churchill Downs Incorporated - Strategy, SWOT and Corporate Finance Report Summary Churchill Downs Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Meera Industries Ltd (540519):企業の財務・戦略的SWOT分析
    Meera Industries Ltd (540519) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • TWi Pharmaceuticals Inc (4180):製薬・医療:M&Aディール及び事業提携情報
    Summary TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a technology based pharmaceutical company that manufactures high barrier generics drugs. The company provides products such as donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, …
  • Aphios Corp-製薬・医療分野:企業M&A・提携分析
    Summary Aphios Corp (Aphios) is a biotechnology company that develops nanotechnology drug delivery platforms. The company provides technology platforms and enhanced therapeutics for the treatment of infectious diseases, cancers and central nervous system disorders. Its therapeutic products include Z …
  • Cloverdale Paint Inc:企業の戦略的SWOT分析
    Cloverdale Paint Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Principal Financial Group Inc.:企業のM&A・事業提携・投資動向
    Principal Financial Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Principal Financial Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Swedish Match AB:企業の戦略・SWOT・財務情報
    Swedish Match AB - Strategy, SWOT and Corporate Finance Report Summary Swedish Match AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • TSO3 Inc (TOS):医療機器:M&Aディール及び事業提携情報
    Summary TSO3 Inc (TSO3) designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The co …
  • Helius Medical Technologies Inc (HSDT):企業の財務・戦略的SWOT分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that provides neurological wellness solutions. The company provides development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides development of tec …
  • M.D.C. Holdings Inc:戦略・SWOT・企業財務分析
    M.D.C. Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary M.D.C. Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Suntory Holdings Ltd:企業の戦略・SWOT・財務情報
    Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Swift Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company’s products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Dubai Electricity and Water Authority:企業の発電所・SWOT分析2018
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • AIG Europe Limited:企業の戦略・SWOT・財務情報
    AIG Europe Limited - Strategy, SWOT and Corporate Finance Report Summary AIG Europe Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bio-Reference Laboratories Inc:企業の戦略的SWOT分析
    Bio-Reference Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Merz Pharma GmbH & Co. KGaA:企業のM&A・事業提携・投資動向
    Merz Pharma GmbH & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merz Pharma GmbH & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Hibbett Sports Inc:戦略・SWOT・企業財務分析
    Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report Summary Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • LG Chem Ltd (051910):電力:M&Aディール及び事業提携情報
    Summary LG Chem Ltd (LG Chem) is a chemical manufacturer. It manufactures and markets petrochemicals, IT and electronic materials, and energy solutions. The company’s product portfolio comprises poly vinyl chloride (PVC), ethylene, propylene, butadiene, benzene, polarizer, glass substrate, semicondu …
  • San Miguel Brewery Inc:企業の戦略・SWOT・財務情報
    San Miguel Brewery Inc - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vector Ltd (VCT):企業の財務・戦略的SWOT分析
    Vector Ltd (VCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆